[2P] Schizophrenia

Thu. Jul 30, 2020 1:30 PM - 3:30 PM Poster Session

*Videos are available throughout the meeting period.

+Add all to schedule

[2P-239] Structural MRI spatial pattern associated with schizophrenia patients in a multivariate approach

*Maeri Yamamoto¹, Bagarinao Epifanio², Itaru Kushima¹, Toshiya Inada¹, Tetsuya Iidaka², Norio Ozaki¹ (1.Department of Psychiatry, Nagoya University, Graduate School of Medicine, Nagoya, Aichi, Japan, 2.Brain & Mind Research Center, Nagoya University, Nagoya, Aichi, Japan)

[2P-240] Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models

*Wen-Sung Lai^1,2,3, Da-Zhong Luo¹, Chia-Yuan Chang¹, Tsung-Ren Huang^1,3, Vincent Studer⁴, Tsu-Wei Wang⁵ (1.National Taiwan University, 2.Graduate Institute of Brain and Mind Sciences, National Taiwan University, 3.Neurobiology and Cognitive Science Center, National Taiwan University, 4.Interdisciplinary Institute for Neuroscience, University of Bordeaux, F-33077, Bordeaux, France, 5.Department of Life Science, National Taiwan Normal University, Taipei, Taiwan)

[2P-242] Enhanced inhibitory synapse formation caused by loss of the synaptic suppressor MDGA1 induces schizophrenic behavioral abnormality

*Tohru Yamamoto¹, Daiki Ojima¹, Atsushi Tanoue², Yu Tada², Naohiro Tanoue², Nozomi Tsushima², Md. Razib Hossain¹, Takeshi Kubota², Hiroo Takahashi¹, Yasushi Kishimoto² (1.Dept Mol Neurobiol, Kagawa Univ, Japan, 2.Dept Biophys, Tokushima Bunri University, Kagawa, Japan)